| Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma W Wick, VK Puduvalli, MC Chamberlain, MJ Van Den Bent, AF Carpentier, ... Journal of clinical oncology 28 (7), 1168, 2010 | 566 | 2010 |
| Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08 PY Wen, WKA Yung, KR Lamborn, PL Dahia, Y Wang, B Peng, LE Abrey, ... Clinical Cancer Research 12 (16), 4899-4907, 2006 | 503 | 2006 |
| Central nervous system cancers, version 3.2020, NCCN clinical practice guidelines in oncology LB Nabors, J Portnow, M Ahluwalia, J Baehring, H Brem, S Brem, ... Journal of the National Comprehensive Cancer Network 18 (11), 1537-1570, 2020 | 334 | 2020 |
| Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme MD Groves, VK Puduvalli, KR Hess, KA Jaeckle, P Peterson, ... Journal of Clinical Oncology 20 (5), 1383-1388, 2002 | 276 | 2002 |
| Inhibition of SOAT1 suppresses glioblastoma growth via blocking SREBP-1–mediated lipogenesis F Geng, X Cheng, X Wu, JY Yoo, C Cheng, JY Guo, X Mo, P Ru, B Hurwitz, ... Clinical Cancer Research 22 (21), 5337-5348, 2016 | 255 | 2016 |
| Brain metastasis from prostate carcinoma: The M. D. Anderson Cancer Center experience IW Tremont‐Lukats, G Bobustuc, GK Lagos, K Lolas, AP Kyritsis, ... Cancer 98 (2), 363-368, 2003 | 253 | 2003 |
| Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia D Sampath, C Liu, K Vasan, M Sulda, VK Puduvalli, WG Wierda, ... Blood, The Journal of the American Society of Hematology 119 (5), 1162-1172, 2012 | 247 | 2012 |
| Treatment of glioblastoma (GBM) with the addition of tumor-treating fields (TTF): a review D Fabian, MP Guillermo Prieto Eibl, I Alnahhas, N Sebastian, P Giglio, ... Cancers 11 (2), 174, 2019 | 197 | 2019 |
| Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma AP Brown, CL Barney, DR Grosshans, MF McAleer, JF De Groot, ... International Journal of Radiation Oncology* Biology* Physics 86 (2), 277-284, 2013 | 190 | 2013 |
| Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study WB Pope, XJ Qiao, HJ Kim, A Lai, P Nghiemphu, X Xue, BM Ellingson, ... Journal of neuro-oncology 108, 491-498, 2012 | 182 | 2012 |
| NCCN guidelines insights: central nervous system cancers, version 1.2017 LB Nabors, J Portnow, M Ammirati, J Baehring, H Brem, N Butowski, ... Journal of the National Comprehensive Cancer Network 15 (11), 1331-1345, 2017 | 181 | 2017 |
| Safety and pharmacokinetic effects of TNP-470, an angiogenesis inhibitor, combined with paclitaxel in patients with solid tumors: evidence for activity in non–small-cell lung … RS Herbst, TL Madden, HT Tran, GR Blumenschein Jr, CA Meyers, ... Journal of clinical oncology 20 (22), 4440-4447, 2002 | 180 | 2002 |
| Targeting DGAT1 ameliorates glioblastoma by increasing fat catabolism and oxidative stress X Cheng, F Geng, M Pan, X Wu, Y Zhong, C Wang, Z Tian, C Cheng, ... Cell metabolism 32 (2), 229-242. e8, 2020 | 179 | 2020 |
| miR‐29b and miR‐125a regulate podoplanin and suppress invasion in glioblastoma MA Cortez, MS Nicoloso, M Shimizu, S Rossi, G Gopisetty, JR Molina, ... Genes, Chromosomes and Cancer 49 (11), 981-990, 2010 | 173 | 2010 |
| A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies MD Groves, MJ Glantz, MC Chamberlain, KE Baumgartner, CA Conrad, ... Neuro-oncology 10 (2), 208-215, 2008 | 131 | 2008 |
| Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma JF De Groot, MR Gilbert, K Aldape, KR Hess, TA Hanna, S Ictech, ... Journal of neuro-oncology 90, 89-97, 2008 | 126 | 2008 |
| Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation D Sampath, GA Calin, VK Puduvalli, G Gopisetty, C Taccioli, CG Liu, ... Blood, The Journal of the American Society of Hematology 113 (16), 3744-3753, 2009 | 106 | 2009 |
| Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM … MD Groves, KR Hess, VK Puduvalli, H Colman, CA Conrad, MR Gilbert, ... Journal of neuro-oncology 94, 229-234, 2009 | 105 | 2009 |
| Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard? I Melguizo-Gavilanes, JM Bruner, N Guha-Thakurta, KR Hess, ... Journal of neuro-oncology 123, 141-150, 2015 | 99 | 2015 |
| TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activation VK Puduvalli, D Sampath, JM Bruner, J Nangia, R Xu, AP Kyritsis Apoptosis 10, 233-243, 2005 | 92 | 2005 |
